CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
107289-20-3 | (R)-2-tert-butyl-6-methyl-1,3-dioxin-4-o ne | 熔点:60-62℃
|
C9H14O3 | 170.20 |
107283-77-2 | cis-(platinum-dichloro(doxorubicin)(tert-butylamine | |
| |
107283-03-4 | 5,12-naphthacenedione, 7,8,9,10-tetrahydro-8-acetyl-10-((3-amino-2,3,6-trideoxy | |
| |
107283-02-3 | heterochromatin-specific nonhistone chromosomal protein hp-1 | |
| |
107276-40-4 | 4-(3-(p-methoxyphenoxy)propoxy)-m-anisidin | |
| |
107271-62-5 | [(2,2,4,4-tetramethylbicyclo[1.1.0]butane- 1,3-diyl)bis(10,9-anthracenediyloxy)]bis[(1,1- dimethylesilan | |
C48H58O2Si2 | 723.15 |
107271-61-4 | [dispiro[cyclohexane-1,2'-bicyclo[1.1.0]butane- 4',1''-cyclohexane]-1',3'-diylbis[[2,6-bis(1,1- dimsilan | |
C48H78O2Si2 | 743.31 |
107269-40-9 | 6,8-dibromo-2-methyl-3-((5-(phenylmethyl)-1,3,4-oxadiazol-4(3h)-quinazolinon | |
| |
107266-08-0 | carvotroline | |
| |
107266-06-8 | gevotroline | |
| |
107264-09-5 | n-fluoropyridinium tetrafluoroborate | 熔点:195-198℃
|
C5H5BF5N | 184.91 |
107264-06-2 | n-fluoro-3,5-dichloropyridinium triflate | 熔点:98-101℃
|
C6H3Cl2F4NO3S | 316.06 |
107264-00-6 | n-fluoro-2,4,6-trimethylpyridinium trifluoromethanesulfonate | 熔点:159-163℃
|
C9H10F4NSO3 | 288.24 |
107263-95-6 | N-氟吡啶三氟甲磺酸盐 n-fluoropyridinium trifluoromethanesulfonate | 熔点:182-187℃
|
C6H5F4NO3S | 247.16 |
107259-49-4 | atalafoline | 密度:1.366±0.06 g/cm3(Predicted) 熔点:155-158 °C 沸点:593.4±50.0 °C(Predicted)
|
C17H17NO6 | 331.32 |
107259-48-3 | aristolochic acid e | |
| |
107259-46-1 | xuelianlactone | |
| |
107259-45-0 | lactiflorasyne | |
| |
107257-29-4 | ro 22-4839 | |
| |
107257-28-3 | pk 14105 | |
C21H20FN3O3 | 381.4 |
107257-16-9 | 3-o-methyl-6-fluoro-dopa | |
| |
107256-99-5 | tamoxifen methiodide | |
| |
107255-72-1 | 5-(o-fluorobenzylidene)-3-((4-phenyl-1-piperazinyl)methyl)-2-4-thiazolidinon | |
| |
107255-71-0 | 5-(o-fluorobenzylidene)-3-(1-piperidinylmethyl)-2-thioxo-4-thiazolidinon | |
| |
107255-70-9 | 5-(p-fluorobenzylidene)-3-((4-phenyl-1-piperazinyl)methyl)-2-4-thiazolidinon | |
| |
107255-69-6 | 5-(p-fluorobenzylidene)-3-(morpholinomethyl)-2-thioxo-4-thiazolidinon | |
| |
107254-86-4 | 5-nitro-2-(3-phenylpropylamino)benzoic acid | |
C16H16N2O4 | 300.31 |
107248-93-1 | cgs 12094 | |
| |
107248-91-9 | calfluxin | |
| |
107241-37-2 | n-decyliminodiacetato-1,2-diaminocyclohexane-platinum(ii | |
| |
107240-22-2 | 5-(m-fluorobenzylidene)-3-((4-phenyl-1-piperazinyl)methyl)-2-4-thiazolidinon | |
| |
107240-21-1 | 5-(m-fluorobenzylidene)-3-(1-piperidinylmethyl)-2-thioxo-4-thiazolidinon | |
| |
107240-20-0 | 5-(m-fluorobenzylidene)-3-(morpholinomethyl)-2-thioxo-4-thiazolidinon | |
| |
107240-13-1 | 5-(p-fluorobenzylidene)-3-(1-piperidinylmethyl)-2-thioxo-4-thiazolidinon | |
| |
107235-75-6 | 4-(cyclohexylcarbonyl)-1-ethyl-6-phenyl-piperazinon | |
| |
107235-74-5 | 4-benzoyl-1-ethyl-6-phenyl-piperazinon | |
| |
107235-71-2 | 4-(cyclohexylcarbonyl)-1-(phenylmethyl)-piperazinon | |
| |
107235-70-1 | 4-(4-nitrobenzoyl)-1-(phenylmethyl)-piperazinon | |
| |
107235-69-8 | 4-benzoyl-1-(phenylmethyl)-piperazinon | |
| |
107235-66-5 | 4,6(1h,5h)-pyrimidinedione, 5-ethyl-5-(1-methylbutyl)-2-((3-methylphenyl)amino) | |
| |
107235-64-3 | 5h)-pyrimidinedione, 5-ethyl-5-(1-methylbutyl)-2-(phenylamino)-6(1h | |
| |
107235-09-6 | trans-4-(4-chloro-3-(trifluoromethyl)phenyl)-3-phenyl-2-piperidinone | |
| |
107235-08-5 | trans-3-phenyl-4-(4-(trifluoromethyl)phenyl)-2-piperidinone | |
| |
107234-98-0 | trans-4-(4-methylphenyl)-3-phenyl-2-piperidinone | |
| |
107234-97-9 | cis-4-(4-methylphenyl)-3-phenyl-2-piperidinone | |
| |
107234-96-8 | 4-dichlorophenyl)-3-phenyl- 4-( trans-2-piperidinon | |
| |
107234-94-6 | trans-4-(4-chlorophenyl)-3-phenyl-2-piperidinone | |
| |
107234-93-5 | cis-4-(4-chlorophenyl)-3-phenyl-2-piperidinone | |
| |
107234-92-4 | trans-3-(4-chlorophenyl)-4-phenyl-2-piperidinone | |
| |
107234-91-3 | cis-3-(4-chlorophenyl)-4-phenyl-2-piperidinone | |
| |